Laura Shawver

2022 - ARS Pharmaceuticals

In 2022, Laura Shawver earned a total compensation of $5.8M as Former Chief Executive Officer at ARS Pharmaceuticals, a 608% increase compared to previous year.

Compensation breakdown

Option Awards$1,426,833
Salary$405,504
Stock Awards$347,912
Other$3,634,797
Total$5,815,046

Shawver received $3.6M in other compensation, accounting for 63% of the total pay in 2022.

Shawver also received $1.4M in option awards, $405.5K in salary and $347.9K in stock awards.

Rankings

In 2022, Laura Shawver's compensation ranked 528th out of 5,625 executives tracked by ExecPay. In other words, Shawver earned more than 90.6% of executives.

ClassificationRankingPercentile
All
528
out of 5,625
91st
Division
Manufacturing
221
out of 3,053
93rd
Major group
Chemicals And Allied Products
68
out of 1,380
95th
Industry group
Drugs
56
out of 1,281
96th
Industry
Pharmaceutical Preparations
40
out of 927
96th
Source: SEC filing on May 1, 2023.

Shawver's colleagues

We found six more compensation records of executives who worked with Laura Shawver at ARS Pharmaceuticals in 2022.

2022

Valerie Odegard

ARS Pharmaceuticals

Chief Scientific Officer

2022

Jonathan Piazza

ARS Pharmaceuticals

Chief Financial Officer

2022

Jeffrey Pepe

ARS Pharmaceuticals

Chief Executive Officer

2022

Richard MSEL

ARS Pharmaceuticals

Chief Executive Officer

2022

Sarina Tanimoto

ARS Pharmaceuticals

Chief Medical Officer

2022

Eric Karas

ARS Pharmaceuticals

Chief Commercial Officer

News

You may also like